CONVENTION ON THE TRANSBOUNDARY EFFECTS OF INDUSTRIAL ACCIDENTS
Article 1
Definitions
Article 2
Scope
Article 3
General provisions
Article 4
Identification, consultation and advice
Article 5
Voluntary extension
Article 6
Prevention
Article 7
Decision-making on siting
Article 8
Emergency preparedness
Article 9
Information to, and participation of the public
Article 10
Industrial accident notification systems
Article 11
Response
Article 12
Mutual assistance
Article 13
Responsibility and liability
Article 14
Research and development
Article 15
Exchange of information
Article 16
Exchange of technology
Article 17
Competent authorities and points of contact
Article 18
Conference of the Parties
Article 19
Right to vote
Article 20
Secretariat
Article 21
Settlement of disputes
Article 22
Limitations on the supply of information
Article 23
Implementation
Article 24
Bilateral and multilateral agreements
Article 25
Status of Annexes
Article 26
Amendments to the Convention
Article 27
Signature
Article 28
Depositary
Article 29
Ratification, acceptance, approval and accession
Article 30
Entry into force
Article 31
Withdrawal
Article 32
Authentic texts
ANNEX 1
HAZARDOUS SUBSTANCES FOR THE PURPOSES OF DEFINING HAZARDOUS ACTIVITIES
PART I
Categories of substances and preparations not specifically named in Part II
Category |
Threshold quantity (Tonnes) |
||
|
200 |
||
|
50 000 |
||
|
20 |
||
|
500-200 |
||
|
500-200 |
||
|
200-50 |
||
|
200 |
||
|
200 |
PART II
Named substances
Substance |
Threshold quantity (Tonnes) |
||
|
500 |
||
|
2 500 |
||
|
10 000 |
||
|
200 |
||
|
25 |
||
|
50 |
||
|
20 |
||
|
50 |
||
|
50 |
||
|
250 |
||
|
75 |
||
|
50 |
||
|
0,75 |
||
|
0,15 |
LD50 (oral)(1) mg/kg body weight LD50 ≤ 25 |
LD50 (dermal)(2) mg/kg body weight LD50 ≤ 50 |
LC50 (3) mg/l (inhalation) LC50 ≤ 0,5 |
Discriminating dose mg/kg body weight |
< 5 |
where the acute oral toxicity in animals of the substance has been determined using the fixed-dose procedure. |
LD50 (oral)(4) mg/kg body weight 25 < LD50 ≤ 200 |
LD50 (dermal)(5) mg/kg body weight 50 < LD50 ≤ 400 |
LC50 (6) mg/l (inhalation) 0,5 < LC50 ≤ 2 |
Discriminating dose mg/kg body weight |
= 5 |
where the acute oral toxicity in animals of the substance has been determined using the fixed-dose procedure. |
LC50 (7) mg/1 LC50 ≤ 10 |
EC50 (8) mg/1 EC50 ≤ 10 |
IC50 (9) mg/1 IC50≤ 10 |
where the substance is not readily degradable, or the log Pow > 3,0 (unless the experimentally determined BCF < 100). |
ANNEX II
Inquiry commission procedure pursuant to Articles 4 and 5
ANNEX III
PROCEDURES PURSUANT TO ARTICLE 4
ANNEX IV
PREVENTIVE MEASURES PURSUANT TO ARTICLE 6
ANNEX V
ANALYSIS AND EVALUATION
Purpose of analysis |
Matters to be considered |
||||||||||||||||||
Emergency planning under Article 8 |
|
||||||||||||||||||
Decision-making on siting under Article 7 |
In addition to items 1 to 5 above:
|
||||||||||||||||||
Information to the public under Article 9 |
In addition to items 1 to 4 above:
|
||||||||||||||||||
Preventive measures under Article 6 |
In addition to items 4 to 9 above, more detailed versions of the descriptions and assessments set out in items 1 to 3 will be needed for preventive measures. In addition to those descriptions and assessments, the following matters should also be covered
|